Clinical Trial: A Phase 1 Study of Single and Multiple Ascending Doses of GV-100

U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07788014) titled 'A Phase 1 Study of Single and Multiple Ascending Doses of GV-100' on Aug. 20.

Brief Summary: This is a first-in-human, multi-part clinical study designed to evaluate the safety, tolerability, pharmacokinetics (PK), food effect, and drug-drug interaction (DDI) potential of GV-100 following oral administration in healthy participants. The study is divided into four parts: Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), Food Effect (FE), and Drug-Drug Interaction (DDI).

Study Start Date: June 23

Study Type: INTERVENTIONAL

Condition: ADPKD (Autosomal Dominant Polycystic Kidney Disease)

Intervention: DRUG: GV-100

GV-10...